VMQ StocksFor the value investor looking to harness academic research in
an actively managed portfolio
Bits and BipsNewsletter delivering insights on linking traditional finance, macro trends and cryptocurrency opportunities to help investors build stronger, more diversified portfolios.
All premium products come with free basic membership.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Learn more about whether Clover Health Investments, Corp. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
As of Thursday, November 19, Clover Health Investments, Corp.’s CLOV share price has dipped by
5.04%, which has investors questioning if this is right time to buy.
As of Wednesday, November 18, Clover Health Investments, Corp.’s CLOV share price has dipped by
6.79%, which has investors questioning if this is right time to buy.
As of Monday, November 09, Clover Health Investments, Corp.’s CLOV share price has surged by
7.16%, which has investors questioning if this is right time to sell.
Learn more about whether Ardent Health, Inc. or Clover Health Investments, Corp. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Tudor Pop
Financial Summary
Share Statistics
CLOV
Industry Median
Percentile (All Stocks)
Market Cap (Mil)
$1,997.1
$1,721.2
56%
Shares Out (Mil)
557.5
80.6
89%
Institutional Ownership
57.3%
87.6%
38%
Float (Mil)
416.7
59.2
83%
Beta
2.48
0.74
96%
Avg Daily Volume (000s)
5,664
613
93%
Price Change (52-week)
60.8%
74.5%
91%
Growth
CLOV
Industry Median
Percentile (All Stocks)
Sales (5yr)
22.8%
10.4%
84%
Net Income (5yr)
8.9%
(0.5%)
53%
EPS (5yr)
35.9%
3.0%
86
Dividends (5yr)
0.0%
0.0%
0%
Cash Flow (5yr)
(23.1%)
(17.4%)
28%
Estimates
Qtrly
Current Fiscal Year
Next Fiscal Year
# of Estimates
1
1
1
Current EPS
($0.030)
$0.140
$0.180
Month Ago EPS
($0.020)
$0.140
$0.150
# Rev Up
0
1
0
# Rev Down
1
0
0
Three Months Ago EPS
($0.020)
$0.140
$0.150
Year/Year Chg
(400.0%)
(183.8%)
(243.7%)
Financials
CLOV
Industry Median
Percentile (All Stocks)
Sales (TTM) (Mil)
$2,739
$1,529
64%
Net Income (TTM) (Mil)
$13
$33
46%
EPS (TTM)
$0.024
$0.300
40%
Operating Cash Flow (TTM) (Mil)
$135
$175
54%
Net Cash Flow (TTM) (Mil)
$78
$7
74%
Long-Term Debt (Q1) (Mil)
$0
$419
0%
Enterprise Value (Q1) (Mil)
$2,313
$2,427
51%
Valuation
CLOV
Industry Median
Percentile (All Stocks)
P/B
5.11
2.56
83%
P/E
186.5
25.9
98%
Dividend Yield
0.0%
0.0%
0%
PEG (5yr hist)
5.2
1.1
89%
Ratios
CLOV
Industry Median
Percentile (All Stocks)
Gross Margin
18.9%
27.3%
19%
Net Margin
0.5%
1.4%
32%
ROA
1.9%
2.4%
54%
ROE
3.4%
7.3%
39%
Liabilities to Assets
48.1%
62.3%
40%
F-Score
5
5
50%
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
CLOV meetings the criteria of 1 screen:
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors